Study S003349

Phase Ib Clinical Study on the Safety, Tolerance, Pharmacokinetics, and Pharmacodynamics of GZR33 and GZR101 in Healthy Adult Male Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06556641
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 28
Start: 2022-12-17
Primary completion: 2023-02-03
Lead sponsor: Gan and Lee Pharmaceuticals, USA
Conditions: Healthy Subjects
Interventions: DRUG:GZR33 Injection; DRUG:GZR101 Injection; DRUG:Placebo; DRUG:Insulin Degludec
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

AUC0-24h [From 0 to 24 hours]
Incidence of adverse events (AE) [From Predose to Day12]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.